- Home
- VERV vs DHIL Comparison
VERV vs DHIL Comparison
Compare VERV & DHIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VERV
- DHIL
- Stock Information
- Founded
- VERV 2018
- DHIL 1990
- Country
- VERV United States
- DHIL United States
- Employees
- VERV N/A
- DHIL N/A
- Industry
- VERV Medicinal Chemicals and Botanical Products
- DHIL Investment Managers
- Sector
- VERV Health Care
- DHIL Finance
- Exchange
- VERV Nasdaq
- DHIL Nasdaq
- Market Cap
- VERV 382.5M
- DHIL 424.8M
- IPO Year
- VERV 2021
- DHIL 1995
- Fundamental
- Price
- VERV $4.79
- DHIL $170.72
- Analyst Decision
- VERV Strong Buy
- DHIL
- Analyst Count
- VERV 4
- DHIL 0
- Target Price
- VERV $25.75
- DHIL N/A
- AVG Volume (30 Days)
- VERV 1.4M
- DHIL 13.9K
- Earning Date
- VERV 11-05-2024
- DHIL 11-04-2024
- Dividend Yield
- VERV N/A
- DHIL 3.52%
- EPS Growth
- VERV N/A
- DHIL 21.33
- EPS
- VERV N/A
- DHIL 17.67
- Revenue
- VERV $24,396,000.00
- DHIL $145,795,446.00
- Revenue This Year
- VERV $84.66
- DHIL N/A
- Revenue Next Year
- VERV N/A
- DHIL N/A
- P/E Ratio
- VERV N/A
- DHIL $9.66
- Revenue Growth
- VERV 219.91
- DHIL 5.76
- 52 Week Low
- VERV $4.31
- DHIL $135.44
- 52 Week High
- VERV $19.34
- DHIL $173.98
- Technical
- Relative Strength Index (RSI)
- VERV 32.80
- DHIL 63.78
- Support Level
- VERV $6.02
- DHIL $168.36
- Resistance Level
- VERV $6.68
- DHIL $171.70
- Average True Range (ATR)
- VERV 0.47
- DHIL 2.86
- MACD
- VERV -0.14
- DHIL 1.49
- Stochastic Oscillator
- VERV 0.25
- DHIL 88.67
About VERV Verve Therapeutics Inc.
Verve Therapeutics Inc is a genetic medicines company pioneering a new approach to the care of cardiovascular disease, transforming treatment from chronic management to single-course gene editing medicines. The company's initial two programs target PCSK9 and ANGPTL3, genes that have been extensively validated as targets for lowering blood lipids such as low-density lipoprotein cholesterol, a root cause of cardiovascular disease. The company views its operations as and manages its business in one operating segment operating exclusively in the United States.
About DHIL Diamond Hill Investment Group Inc.
Diamond Hill Investment Group Inc sponsors, markets, and provides investment advisory and related services to various U.S. and foreign clients including mutual funds, separate accounts, and private investment funds. The company's objective is to fulfill a fiduciary duty to clients and secondary objectives to achieve an adequate long-term return for shareholders. The company generates its revenue from Investment advisory and fund administration fees.